B. Balbi (Veruno, Italy), S. Loukides (Athens, Greece), T. Mueller (Aachen, Germany), I.M. Adcock (London, United Kingdom)
LATE-BREAKING ABSTRACT: Risk factors of difficult-to-control adult-onset asthma G. Westerhof, S. de Nijs, E. Bel (Amsterdam, Netherlands)
| |
LATE-BREAKING ABSTRACT: Stratification of patients with COPD by frequence of exacerbations is an essential step for what to treat in COPD. - A survey in a real life COPD population D. Klopf, J. Rumpf, P. Maier-Stocker, K. Thomas, C. Koehl (Nuernberg, HOF, Amberg, Lauf, Muenchen, Germany)
| |
LATE-BREAKING ABSTRACT: Relationships between exhaled nitric oxide and lung function profiles in severe asthma Q. Zhnag, E Guo, N. Li, M. He, J. Li, J. Zheng (Guangzhou, China)
| |
Are air pollutants confounders in relation to weather variables as triggers for acute asthma? C. Gouder, E. Gerada, J. Micallef, S. Gouder, R. Pullicino, S. Montefort (Msida, Malta)
| |
Refractory asthma in elderly patients in the UK R. Chaudhuri, C. McSharry, L. Heaney, R. Niven, C. Brightling, A. Menzies-Gow, C. Bucknall, A. Mansur, W. T. N. Lee, M. Shepherd, M. Spears, N. Thomson (Glasgow, Belfast, Manchester, Leicester, London, Birmingham, United Kingdom)
| |
Relevance of hemoglobin A1c and acute exacerbations of chronic obstructive pulmonary disease H. Aoki, T. Hisada, M. Yatomi, H. Tsurumaki, R. Yoshino, K. Dobashi, T. Ishizuka, M. Mori (Maebashi, Shibukawa, Fukui, Japan)
| |
Follow up of asthmatic patients after admission to intensive care unit (ICU) due to an acute exacerbation E. Perez Guzman, N. Marina Malanda, R. Diez Arnesto, A. Sagarna Aguirrezabala, A. Urrutia Gajate, J. B. Galdiz Iturri (Barakaldo, Spain)
| |
Use of beta-agonist therapy prior to hospital attendance for severe exacerbations of asthma M. Patel, J. Pilcher, R. Hancox, D. Sheahan, D. Shaw, M. Weatherall, R. Beasley (Wellington, Hamilton, Dunedin, Tauranga, New Zealand; Nottingham, United Kingdom)
| |
Predictors of severe asthma exacerbations, poor asthma control and beta-agonist overuse in adult asthma M. Weatherall, M. Patel, J. Pilcher, H. Reddel, D. Shaw, R. Beasley (Wellington, New Zealand; Nottingham, United Kingdom; Sydney, Australia)
| |
Microparticles in stable and exacerbated COPD patients I. Ruzsics, S. Singoszki, B. Illés M., V. Sárosi, Z. Balikó, M. Tokés-Füzsi, T. Koszegi, G. Woth, I. Vermes, G. L. Kovács (Pécs, Hungary)
| |
Monitoring oxidative stress in the lung: Changes in superoxide dismutase (SOD) activity during the course of acute exacerbations in COPD I. Barta, O. Drozdovszky, B. Antus (Budapest, Hungary)
| |
Frequency of COPD exacerbations and severity of COPD R. Coelho, A. S. Santos, R. Rosa, A. Borba, L. Semedo, J. Cardoso (Lisbon, Portugal)
| |
COPD assessment test (CAT) in acute exacerbation of COPD and in the long term follow up of COPD patients N. Rovina, M. Symiakakis, A. Tsioka, A. Travlos, K. Vlachos, A. Koutsoukou, N. Koulouris (Athens, Greece)
| |
BNP level in patients with COPD exacerbations S. S. Bucsa, P. I. Calistru (Bucharest, Romania)
| |
Evaluation of the GOLD 2011 severity criteria across the COPD spectrum P. Short, J. Chalmers, P. Williamson, A. Singanayagam, A. Akram, B. Lipworth, S. Schembri (Dundee, London, Edinburgh, United Kingdom)
| |
Modeling an electronic field registry - An adaptation approach to climate change in mild altitude cities for early prediction of heat related COPD exacerbations B. Parandian, M. Hanisch, F. Meier, M. Grabenhorst, U. Liebers, M. Jehn, C. Witt (Berlin, Germany)
| |
Cross sectional and longitudinal analysis of the relationship between the COPD assessment test (CAT), multi detector-row CT and pulmonary function test T. Suzuki, K. Iesato, N. Kawata, J. Terada, S. Sakao, Y. Kasahara, M. Suzuki, N. Yanagawa, N. Tanabe, K. Tatsumi (Chiba City, Japan)
| |
Innate immunity but not NLRP3 inflammasome activation correlates with severity of stable COPD A. Di Stefano, G. Caramori, A. Barczyk, C. Vicari, P. Brun, A. Zanini, F. Cappello, E. Garofano, A. Padovani, M. Contoli, A. Durham, P. Barnes, K. F. Chung, A. Papi, I. Adcock, B. Balbi (Veruno, Tradate, Ferrara, Padova, Palermo, Italy; Slaskiego, Poland; London, United Kingdom)
| |
Predicting clinical course of alpha 1 anti-trypsin deficiency (AATD) using GOLD 2011 classification A. Pillai, A. Turner, R. Stockley (Birmingham, United Kingdom)
| |